List of articles with "North Chicago"

SKYRIZI Approved for Kids

2026-06-26 20:58:52

United States AbbVie North Chicago Skyrizi Risankizumab

Daniel D. King Honored

2026-06-26 18:46:15

United States North Chicago American Academy Nursing Daniel D. King

AbbVie Venetoclax EC Approval

2026-06-25 02:54:22

United States AbbVie North Chicago CLL venetoclax

AbbVie Acquires Apogee

2026-06-22 11:17:06

USA Apogee AbbVie North Chicago Immunology

AbbVie Acquires Apogee

2026-06-22 11:11:55

USA AbbVie North Chicago Immunology Apogee Therapeutics

AbbVie Announces Dividend

2026-06-18 20:24:34

USA Dividend AbbVie North Chicago SP Dividend Aristocrats

Glecaprevir/Pibrentasvir Approval

2026-06-18 01:29:21

United States North Chicago Glecaprevir Pibrentasvir HCV

AbbVie Venetoclax Update

2026-06-12 07:22:59

USA AbbVie North Chicago CLL venetoclax

AbbVie Presents CLL Study

2026-06-12 07:21:26

USA AbbVie North Chicago CLL VENCLYXTO

AbbVie ASCO 2026 Reveal

2026-06-10 05:12:36

United States oncology AbbVie North Chicago ASCO 2026

AbbVie Blood Cancer Insights

2026-06-08 12:37:00

USA Blood Cancer Epcoritamab AbbVie North Chicago

AbbVie at EHA 2026

2026-06-08 12:18:14

USA Blood Cancer AbbVie North Chicago EHA 2026

AbbVie IBD Updates

2026-06-03 02:30:40

United States AbbVie North Chicago IBD Risankizumab

AbbVie at Goldman Sachs

2026-06-02 12:49:47

USA Goldman Sachs Healthcare Conference AbbVie North Chicago

VENCLYXTO® Label Expanded

2026-05-29 12:14:35

USA AbbVie North Chicago CLL VENCLYXTO

AbbVie's VENCLYXTO Update

2026-05-29 12:13:21

USA AbbVie North Chicago CLL Treatment VENCLYXTO

FDA Approves DECNUPAZ

2026-05-27 22:20:20

USA AbbVie North Chicago BPDCN DECNUPAZ

AbbVie Makes FDA Move

2026-05-25 02:19:53

United States AbbVie North Chicago Alopecia Areata Upadacitinib

MAVIRET® Makes Headway

2026-05-22 12:13:01

USA AbbVie North Chicago Hepatitis C MAVIRET

AbbVie Crohn's Treatment

2026-05-22 02:20:27

United States Crohn's Disease AbbVie North Chicago Risankizumab

Positive Opinion for Boey®

2026-05-21 20:13:27

United States North Chicago Allergan Aesthetics TrenibotulinumtoxinE Boey

AbbVie at Healthcare Conference

2026-05-06 12:22:57

United States Healthcare Conference pharmaceuticals AbbVie North Chicago

New Scleroderma Drug

2026-04-30 21:59:49

United States North Chicago BLR Bio Scleroderma BLR-200

AbbVie Q1 2026 Results

2026-04-29 11:50:19

USA AbbVie North Chicago Skyrizi RINVOQ

FDA Approval Request

2026-04-27 12:12:21

USA Crohn's Disease AbbVie North Chicago Skyrizi

AbbVie Updates on TrenibotE

2026-04-23 20:11:16

United States FDA AbbVie North Chicago TrenibotulinumtoxinE

TrenibotE Data Unveiled

2026-03-30 12:23:25

USA North Chicago Allergan Aesthetics TrenibotulinumtoxinE AAD 2026

NCI Grant for Cancer Research

2026-03-26 17:04:46

United States pancreatic cancer North Chicago Rosalind Franklin Research Grant

Innovative Research at AMWC 2026

2026-03-26 08:14:32

United States North Chicago Allergan Aesthetics TrenibotulinumtoxinE BOTOX®

JUVÉDERM®'s New Era

2026-03-26 07:20:18

USA North Chicago Allergan Aesthetics JUVÉDERM® HA injectables

FDA Approves Venetoclax

2026-03-25 02:54:06

United States AbbVie North Chicago CLL venetoclax

AbbVie and MLB Collaboration

2026-03-24 12:33:57

USA North Chicago AbbviesCancerCampaign MLBPartnership StandUpToCancer

Skyrizi Phase 3 Results

2026-03-23 01:29:14

United States Crohn's Disease North Chicago Skyrizi Risankizumab

Helix 51 Incubator Growth

2026-03-12 16:10:24

United States North Chicago Helix 51 Rosalind Franklin Biotech Expansion

ABBV-295 Weight Loss

2026-03-09 12:34:55

USA Weight Management AbbVie North Chicago ABBV-295

Ubadacitinib Approval

2026-02-25 03:06:19

United States AbbVie North Chicago Vitiligo Ubadacitinib

AbbVie $380M Investment

2026-02-23 16:05:04

United States Active Pharmaceutical Ingredient AbbVie North Chicago

FDA Approval for CLL Treatment

2026-02-20 07:08:37

USA North Chicago CLL VENCLEXTA® Acalabrutinib

RFU Expands Clinical Research

2026-02-19 17:39:43

United States Clinical Trials North Chicago Rosalind Franklin University CCRII

AbbVie Quarterly Dividend

2026-02-19 15:22:58

United States Dividend AbbVie North Chicago NYSE ABBV

AbbVie 2025 Financial Results

2026-02-04 12:56:10

United States AbbVie North Chicago Skyrizi IPRD

RINVOQ® Approval for Vitiligo

2026-02-03 13:11:50

USA AbbVie North Chicago RINVOQ Vitiligo

RFU Researcher Awarded NIH Grant

2026-01-20 18:22:29

United States NIH Grant North Chicago Rosalind Franklin Univ Hongkyun Kim

Epcoritamab Phase 3 Results

2026-01-16 18:45:38

USA Epcoritamab AbbVie North Chicago DLBCL

AbbVie and Trump Agreement

2026-01-12 23:41:17

USA AbbVie North Chicago TrumpRx ALPHAGAN

AbbVie and RemeGen License Agreement

2026-01-12 12:43:48

United States AbbVie North Chicago RemeGen RC148

Innovative Cancer Therapy

2026-01-07 19:05:36

United States Glioblastoma North Chicago UP Oncolytics RFU

RFU NIH Funding for Research

2025-12-18 18:11:30

United States NIH Grant North Chicago Rosalind Franklin Joanna Dabrowska

Tolmar's New Lab

2025-12-16 22:11:13

United States North Chicago Rosalind Franklin Tolmar Pharmaceutical Lab

Atogepant Trial Insights

2025-12-10 05:29:28

USA AbbVie North Chicago Migraine Atogepant